Without transparency we are left to our imaginations and piecing together possibilities, then we wait and wonder. But this is not a transparent process so we have to trust that Dr. Missling isn’t wasting time.
He is not heartless. Look at the way he goes about handling the rare disease population, designing the trials around their needs. Who needs more consideration than those that are compromised in every aspect of life? Is anyone else changing the process to accommodate the needs of those that can do nothing?
The rare disease group didn’t mention anyone but Anavex that I remember.
I think you are spot on. The true believers here have absolutely no objectivity when it comes to Missling. He has never been seriously challenged about his lack of transparency and constant delays over forecasted trial data. Maybe he’s done everything right and all is great and maybe it’s not. We won’t know until somebody with some influence asks the right questions and demands some answers and he clears the air by issuing an update. Would love to blissfully float around thinking everything is great but that is a dangerous way to invest. We deserve an update NOW.
News 
Market Data 
Discover 
AI
